Position in ARWR
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$13,867,377
+$2,866,286 QoQ
Shares Held
170,131
-3.0% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#79
of 499 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PINNACLE ASSOCIATES LTD holds $169,348,366 across 22 Biotechnology names. ARWR ranks #4 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
81,247 | $50,660,754 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
419,752 | $33,282,136 | |
| 3 | CYTK |
Cytokinetics Inc
|
202,440 | $17,245,863 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
170,131 | $13,867,377 | |
| 5 | STTK |
Shattuck Labs, Inc.
|
1,871,442 | $12,987,807 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
22,375 | $11,114,333 | |
| 7 | INCY |
Incyte Corp
|
68,633 | $7,780,236 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
70,435 | $5,745,382 |
All Filings in ARWR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,867,377 | 170,131 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $11,001,091 | 175,456 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $12,724,904 | 191,669 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $7,012,299 | 203,314 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,342,663 | 211,561 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1,798,403 | 141,162 | Shares | Sole | 2025-05-06 | |
| No filing history on record for this holder in this stock. | ||||||